- Home
- SXTP vs NAOV Comparison
SXTP vs NAOV Comparison
Compare SXTP & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- NAOV
- Stock Information
- Founded
- SXTP 2010
- NAOV 2003
- Country
- SXTP United States
- NAOV United States
- Employees
- SXTP N/A
- NAOV N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- NAOV Industrial Specialties
- Sector
- SXTP Health Care
- NAOV Health Care
- Exchange
- SXTP Nasdaq
- NAOV Nasdaq
- Market Cap
- SXTP 1.6M
- NAOV 1.5M
- IPO Year
- SXTP 2023
- NAOV N/A
- Fundamental
- Price
- SXTP $0.90
- NAOV $0.69
- Analyst Decision
- SXTP Hold
- NAOV
- Analyst Count
- SXTP 1
- NAOV 0
- Target Price
- SXTP N/A
- NAOV N/A
- AVG Volume (30 Days)
- SXTP 87.9K
- NAOV 234.5K
- Earning Date
- SXTP 11-26-2024
- NAOV 11-14-2024
- Dividend Yield
- SXTP N/A
- NAOV N/A
- EPS Growth
- SXTP N/A
- NAOV N/A
- EPS
- SXTP N/A
- NAOV N/A
- Revenue
- SXTP $462,612.00
- NAOV $3,291,000.00
- Revenue This Year
- SXTP $267.05
- NAOV N/A
- Revenue Next Year
- SXTP $181.82
- NAOV N/A
- P/E Ratio
- SXTP N/A
- NAOV N/A
- Revenue Growth
- SXTP 12.07
- NAOV 227.79
- 52 Week Low
- SXTP $0.70
- NAOV $0.46
- 52 Week High
- SXTP $18.36
- NAOV $1.55
- Technical
- Relative Strength Index (RSI)
- SXTP 47.11
- NAOV 56.05
- Support Level
- SXTP $0.87
- NAOV $0.62
- Resistance Level
- SXTP $1.14
- NAOV $0.74
- Average True Range (ATR)
- SXTP 0.12
- NAOV 0.05
- MACD
- SXTP 0.02
- NAOV 0.01
- Stochastic Oscillator
- SXTP 53.88
- NAOV 66.16
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.